Myelofibrosis - 57 Studies Found
Completed |
: Clinical Trial of Aplidin® in Patients With Primary Myelofibrosis : Myelofibrosis : 2010-06-22 : Drug: APLIDIN (plitidepsin) Aplidin® (plitidepsin) ly |
Active, not recruiting |
: Decitabine in Treating Patients With Myelofibrosis :
|
Recruiting |
: P1101 in Treating Patients With Myelofibrosis :
|
Recruiting |
: Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg : Myelofibrosis : 2016-03-08 :
|
Active, not recruiting |
: Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence : Primary Myelofibrosis : 2010-07-15 :
|
Recruiting |
: Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis :
|
Completed |
: A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis : Myelofibrosis : 2008-07-17 : Drug: SAR302503 (TG101348) orally administered, once a day |
Completed |
: Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients : Myelofibrosis : 2011-04-21 : Drug: Ruxolitinib Ruxolitinib was supplied as SR and IR formulated tablets. |
Recruiting |
: Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis : Myelofibrosis : 2016-08-26 |
Active, not recruiting |
: Lenalidomide for Patients With Myelofibrosis (MF) : Myelofibrosis : 2006-07-14 :
|